Opportunities and Challenges in Drug Development for Pediatric Cancers
Theodore W. Laetsch(Children's Hospital of Philadelphia), Lucas Moreno(Vall d'Hebron Hospital Universitari), Steven G. DuBois(University of California, San Francisco), Margaret E. Macy(Children's Hospital Colorado), Julia Glade Bender(Columbia University Irving Medical Center)
Cited by 70
Related Papers
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
|The Lancet Oncology|2019|341